Sign in
4

Changes in Ownership

Serina Therapeutics, Inc. Filed Acc 0001708599-25-000078

Chief Scientific Officer sold 6,500 shares at $5.89 ($38,285)

  • Chief Scientific Officer acquired 6,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Moreadith Randall · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-07-28 Exercise or conversion : show line 1 in the form +6,500 $0.06 $390 6,500 D
2025-07-28 Sale : show line 2 in the form −6,500 $5.89 $38,285 0 D
Open-market sales · 6,500 sh · avg $5.89 · $38,285

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-07-28 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −6,500 488,686 D
Loading xslF345X05/wk-form4_1753783796.xml…